GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » CHC Healthcare Group (TPE:4164) » Definitions » EV-to-Revenue

CHC Healthcare Group (TPE:4164) EV-to-Revenue : 3.20 (As of Jun. 08, 2024)


View and export this data going back to 2012. Start your Free Trial

What is CHC Healthcare Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CHC Healthcare Group's enterprise value is NT$11,934 Mil. CHC Healthcare Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was NT$3,734 Mil. Therefore, CHC Healthcare Group's EV-to-Revenue for today is 3.20.

The historical rank and industry rank for CHC Healthcare Group's EV-to-Revenue or its related term are showing as below:

TPE:4164' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.11   Med: 3.97   Max: 6.53
Current: 3.18

During the past 13 years, the highest EV-to-Revenue of CHC Healthcare Group was 6.53. The lowest was 2.11. And the median was 3.97.

TPE:4164's EV-to-Revenue is ranked worse than
88.42% of 95 companies
in the Medical Distribution industry
Industry Median: 0.58 vs TPE:4164: 3.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-08), CHC Healthcare Group's stock price is NT$52.10. CHC Healthcare Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was NT$20.68. Therefore, CHC Healthcare Group's PS Ratio for today is 2.52.


CHC Healthcare Group EV-to-Revenue Historical Data

The historical data trend for CHC Healthcare Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CHC Healthcare Group EV-to-Revenue Chart

CHC Healthcare Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 3.46 3.86 3.57 3.52

CHC Healthcare Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.82 4.63 4.29 3.52 3.64

Competitive Comparison of CHC Healthcare Group's EV-to-Revenue

For the Medical Distribution subindustry, CHC Healthcare Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CHC Healthcare Group's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where CHC Healthcare Group's EV-to-Revenue falls into.



CHC Healthcare Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

CHC Healthcare Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=11933.519/3734.445
=3.20

CHC Healthcare Group's current Enterprise Value is NT$11,934 Mil.
CHC Healthcare Group's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3,734 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group  (TPE:4164) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

CHC Healthcare Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=52.10/20.682
=2.52

CHC Healthcare Group's share price for today is NT$52.10.
CHC Healthcare Group's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$20.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CHC Healthcare Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of CHC Healthcare Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CHC Healthcare Group (TPE:4164) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Xing’ai Road, Neihu District, Taipei, TWN, 114067
CHC Healthcare Group is a Taiwan based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, and repairs maintenance and other services.

CHC Healthcare Group (TPE:4164) Headlines

No Headlines